and E-fragments exhibit more than 10-fold greater native fibrinogen antigenic expression than the sum of the constituent fragments. This suggests the presence of a non-covalently associated native complex of the D-and E-fragments, and implies contiguity of the Dand E-fragments in the native fibrinogen molecule. The cleavage-associated neoantigen, fg-Dn.0, is also generated in vivo and is generically demonstrable in the plasma of patients with various forms of in vivo fibrinolysis.
A B S T R A C T Physiological degradation of fibrinogen
by plasmin leads to a recognized series of intermediate and stable terminal cleavage fragments and is associated with complex modulation and progressive loss of native antigenic expressions. Early in association with progressive plasmin cleavage, a stable cleavage-associated neoantigen, present in the D-fragment region of the molecule, is exposed in vitro and can be recognized by competitive inhibition radioimmunoassay with specific antiserum. It is demonstrated that there is an approximate equimolar expression of the cleavage-associated neoantigen, fg-Dneo, on the X-, Y-, and D-fragments and no recognizable (< 10') expression by fibrinogen or by the E-fragment. The X-fragment contains two D regions in respect to total D-fragment-associated antigenic expressions but unitary expression of fg-Dneo is observed. The Y-fragment appears to contain one Dfragment region in respect to total D-fragment-associated antigens and exhibits close to unitary expression of fg-Dneo. Terminal cleavage digests containing the Dand E-fragments exhibit more than 10-fold greater native fibrinogen antigenic expression than the sum of the constituent fragments. This suggests the presence of a non-covalently associated native complex of the D-and E-fragments, and implies contiguity of the Dand E-fragments in the native fibrinogen molecule. The cleavage-associated neoantigen, fg-Dn.0, is also generated in vivo and is generically demonstrable in the plasma of patients with various forms of in vivo fibrinolysis.
These studies offer a precise immunochemical system, based upon defined molecular events, for the investigation of physiological and pathophysiological cleavage of fibrinogen. By contrast with other approaches to the This work was presented in part at the American Society of Hematology Meetings, San Francisco, Calif., December 1971.
INTRODUCTION
The cleavage of fibrin by plasmin has been viewed as the terminal physiologic event in blood coagulation, serving as a scavenger process to preserve the integrity of the vascular system. More recently it has become evident that physiologic and pathogenetic significance must be attributed to the products of this enzymatic degradation (1) (2) (3) (4) (5) . The appearance of non-coagulable fibrinogen-related antigenic material in serum is observed in association with diverse disease states in man and apparently reflects fibrinolysis secondary to in vivo coagulation (6) (7) (8) . Catabolism of fibrinogen also may occur through direct enzymatic degradation with release of fibrinogen cleavage fragments.
Degradation of fibrinogen by plasmin in vitro is limited, and approximately 70% of the original molecule is retained in the form of two terminal protein fragments (9, 10) . With limited plasmin cleavage of fibrinogen or fibrin, discrete intermediate protein fragments can be recognized (11) . Immunologic studies of the cleavage fragments have been limited to relatively qualitative techniques (11, 12) , and antigenic expressions specific for cleavage fragments, but not expressed by the parent molecule, had not been demonstrated.
We have recently reported the emergence of a specific neoantigen on the D-fragment (fg-D) 1 of fibrino- (Fig. 3) . Sensitivity for each fragment by immunoelectrophoresis was fg-X = 25 ug/ml, fg-Y = 50 ,g/ ml, fg-D = 50 ,ug/ml, and fg-E = 50 ug/ml. Immunoelectrophoresis and gel diffusion. Immunoelectrophoretic analysis was performed in 1% agar as previously described (14) . 10 /Al samples at 1 mg/ml were electrophoresed at 5.5 V/cm for 75 min and precipitins developed with 100 /Al of rabbit anti-fg. Ouchterlony gel double diffusion was performed as previously described (13) .
Radicimmunoassay. Quantitative radioimmunochemical studies were performed in a four compartment double antibody system as previously described (13 (23) using goat anti-fg antisera. This assay is generically similar to other reported radial immunodiffusion assays (24, 25 (29) . The primary diagnostic criterion for in vivo fibrinolysis was the presence of serum cleavage products of > 5.0 mg/100 ml. All patients also met at least three of four secondary criteria suggesting associated disseminated intra- vascular coagulation: (1) platelets < 140,000/mm'; (2) prolonged thrombin time (2 SD greater than control); (3) prothrombin time > 17 s; and (4) reduced plasma fibrinogen < 147 mg/100 ml (29) .
RESULTS
Consideration of the experimental data is facilitated by reference to Fig. 1 Fg-D and fibrinogen were clearly discriminated by competitive inhibition using absorbed anti-fg-D (Fig.  6 ). Fg-D exhibits semilogarithmic competitive inhibition from 3.3 X 10' to 1.0 X 10' M. Isolated fibrinogen and plasma fibrinogen exhibit negligible binding of antibody; at 1.65 X 10' M fibrinogen less than 7% competitive inhibition is observed. Thus, absorption of antifg-D with fibrinogen, results in an antiserum (anti-fgDn.e) which specifically recognizes antigenic sites on the fg-D fragment of fibrinogen not exposed on the .parent fibrinogen molecule, and permits specific assay of the cleavage-associated neoantigenic expression, fgDneo.
The demonstration of a cleavage-associated neoantigen suggests that two events may contribute to the composite antigenic expressions of the fibrinogen cleavage products: (a) the loss and modulation of native fibrinogen antigens; and (b) the emergence and modulation of unique cleavage-associated neoantigens. These two events can be assessed independently. Employing anti-fg and ['I]fibrinogen in the competitive inhibition radioimmunoassay, it is possible to qualitatively assess loss or modulation of native fibrinogen antigens during cleavage. Systematic and sequential loss of native fibrinogen antigens closely parallels the cleavage process (Table I ). Significant loss of native antigenic expression is associated with the initial cleavage of fibrinogen to fg-X. Although fg-X represents 80% of the parent molecule it expresses only 36% of the native antigens recognized by this antifibrinogen antiserum. A similar disproportionate loss of native antigenic expression relative to molecular weight is noted during subsequent cleavage with expression of native antigens as fibrinogen> fg-X> fg-Y> fg-D: E> fg-D> fg-E. The competitive inhibition slope, a reflection of antibody binding affinity, differs significantly with each fragment and indicates qualitative differences in the antigenic expression of each fragment. It is noteworthy that the sum of the native antigenic expressions of isolated fg-D and isolated fg-E is markedly deficient relative to putative fg-D: E core, indicative of marked loss of native antigenic expression upon separation of fg-D and fg-E. This data independently suggests the existence of the fg-D: E core as a complex, indicates that some native conformational antigens of intact fibrinogen are dependent on the association of fg-D and fg-E, and also implies conformational contiguity of these fragments in the parent molecule.
The expression of fg-D-associated antigens during progressive plasmin cleavage of fibrinogen was also investigated by competitive inhibition assays employing [ Competitive inhibition by fibrinogen cleavage fragments in the anti-fg-Dneo system provides more precise and discriminating results (Fig. 7B) . Parallel inhibition profiles are observed with fg-X, fg-Y, putative fg-D: E core, and fg-D indicating that the cleavage-associated neoantigenic expression, fg-Dneo, is exposed in the initial cleavage by plasmin of fibrinogen to fg-X. The neoantigen is qualitatively identical throughout the sub- Qtantitative differences noted in Fig. 7B are further considered in Table II . The slope of each inhibition profile, an indication of the binding affinity of specific antibody molecules for the neoantigen site, confirms that expression of fg-Dneo is qualitatively identical on each fragment except fg-E. The concentration of given fragments required for 50% inhibition reflects quantitative differences in fg-Dneo expression on these molecular fragments. The integer relationship between fg-D and fg-X appears quite significant, and indicates that only one neoantigenic site is exposed on the fg-X fragment, though two fg-D regions have been proposed (11) and were supported by quantitative assay of total fg-D related antigens expressed on fg-X. The number of fg-D.es sites calculated from fg-Y and putative fg-D: E core differ slightly from unity although expression of the fg-Dneo expression appears qualitatively identical to that observed with standard fg-D. Such variations from integer values could arise from minor differences in the estimated molecular weights of fg-Y and putative fg-D: E core or due to complete steric hindrance of the fg-Dueo site on a small percent of molecules.
The possibility that the cleavage of fibrinogen, or fibrin, in vivo would also lead to expression of fg-Dneo was evaluated, and the results are illustrated in Fig. 8 . Utilizing a concentration of anti-fg-Dn.o sufficient to bind 41% of the [5I]fg-D, the plasmas from two normal individuals (C100 and C101) demonstrated no recognizable fg-Dneo activity. These plasmas were also devoid of serum fibrinogen or fibrin cleavage products by radial diffusion assay. By contrast, when control plasma C100 was exposed to plasmin (4 A'g plasmin/ml plasma at 370C for 3 h), fg-Dneo expression was readily generated as indicated by the competitive inhibition of ["I] fg-D binding. Plasmas from two patients with metastatic carcinoma and moderate levels of serum cleavage products by radial immunodiffusion ( X 100 = 5 mg/100 ml; X 101 = 8 mg/100 ml) were also assayed (8, 32, 33) . Both produced semilogarithmic inhibition parallel to that produced by the in vitro cleaved plasma sample, indicating the appearance in vivo of fg-Dneo indistinguishable from that generated in vitro. The lateral displacement of the curves reflects the quantity of neoantigen present and correlates in a general fashion with the levels of cleavage products detected by radial diffusion. Although the relative dis- tribution of each type of cleavage fragment cannot be determined independently, the molar content of the sum of fg-X, fg-Y, fg-D: E, and fg-D can be precisely calculated.
Further evidence for the generation of fg-Dneo in vivo is given in Table III . Plasmas were selected from patients with diseases associated with disseminated intravascular coagulation and the presence of circulating fibrin or fibrinogen cleavage fragments, e.g., metastatic carcinoma (8, 32, 33) , abruptio placentae (6, 34), consumptive coagulopathy (disseminated intravascular coagulation) (8, 35, 36) , meningococcal meningitis (37, 38) , and endotoxic shock (39, 40) . Serum cleavage fragments, primary evidence for in vivo fibrinolysis, were present in all (17-300 mg/100 ml). Normal plasma samples contained no detectable (< 0.5 mg/100 ml) serum cleavage fragments. All patient plasmas were positive for fg-Dneo, whereas normal plasmas were negative. The fg-Dneo titer of plasma indicates wide variations in the concentrations of the cleavage-associated neoantigen in these diverse clinical states. In all cases fg-Dneo was detectable at relatively high dilution of the plasmas, indicating considerable sensitivity of the fgDneo radioimmunoassay. Since each cleavage fragment, except fg-E, expresses the same quantity of neoantigen, results can be expressed in molar concentrations by relating them to standard inhibition produced by fg-D. These data clearly demonstrate the emergence of the cleavage-associated neoantigen, fg-Dneo, in vivo, and they further suggest that this neoantigenic marker may prove valuable in a direct investigative assay of plasma for in vivo fibrinolysis. DISCUSSION Although several models can be conceived to explain the emergence of neoantigenic expressions, the cleavage-associated neoantigen of fibrinogen, fg-Dneo, appears to arise through steric exposure of cryptic amino acid sequences in native fibrinogen (14) . The quantitative and qualitative identity of the neoantigen on the various cleavage fragments as described in this study further supports this model. With the marked modulation of native antigenic expressions, it seems unlikely that an antigenic expression determined by conformation would remain entirely constant during cleavage. According to the steric model (14) the sequence of events illustrated in Fig. 9 is proposed and is consistent with the expression of the cleavage-associated neoantigen observed in this study. Although the conformation of native fibrinogen remains highly debatable (41, 42) , it is known that the molecule is dissociable into three pairs of polypeptide chains (43) The modulation and loss of native antigenic determinants of fibrinogen during cleavage is disproportionate in respect to the loss of mass and suggests that many of the native determinants are conformationally dependent or associated with small peptides. This is consistent with the demonstration of substantial differences in helical content of fg-D, fg-E, and fibrinogen which might reflect changes in conformation with cleavage (45) . The existence of a non-covalently associated fg-D: E core, rather than a simple mixture of these two fragments in free solution, is indicated by the much greater native fibrinogen antigenic expression of fg-D: E as compared with either constituent fragment alone or the sum of native antigenic expressions of the two fragments. Total fg-D antigens are also incompletely expressed by fg-D: E. Such behavior supports the existence of a noncovalently associated bimolecular core, indicates that it is a native molecular conformation, and implies that these two fragments are integrally related in the intact fibrinogen molecule through conformation or by the presence of hypothetical small anti-genic peptides which are lost during the dissociation of the fg-D: E core (46) .
The emergence of fg-Dn.o in vivo is indicated by the assay of plasmas from patients with various forms of in vivo fibrinolysis. The expression of fg-Dneo in vivo is qualitatively identical to the neoantigen generated by incubation of plasmin with normal human plasma. While other physiologic enzymes such as the leukocyte proteases are also capable of cleaving fibrinogen and may be of pathophysiological significance, the expression of the neoantigen on these degradation products differs from the expression of neoantigen on plasmin-generated fragments (14) . The present study is compatible with plasmin as the major enzyme in the production of cleavage products in disease-related conditions.
The assay system for cleavage, based on the detection of fg-Dneo, appears to be highly sensitive and offers distinct advantages over currently employed clinical and investigative assay systems (6-8, 38, 39, 47 (50) . The loss and segregation of antigenic determinants during plasmin cleavage of fibrinogen or fibrin precludes equal sensitivity to all fibrinogen-related antigens. (c) With a firm molecular basis for fg-Dneo expression, interpretation, and assessment of associated pathophysiologic mechanisms may be more effectively achieved.
